Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aripiprazole in Children and Adolescents With Bipolar Disorder and ADHD: A Randomized Double Blind Placebo Controlled Trial

NCT00116259 is registered in ClinicalTrials.gov with Federal University of Rio Grande do Sul as lead sponsor.

NCT NCT00116259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00116259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aripiprazole in Children and Adolescents With Bipolar Disorder and ADHD: A Randomized Double Blind Placebo Controlled Trial
Lead sponsor
Federal University of Rio Grande do Sul
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2005
Completion date
February 29, 2008
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder, bipolar disorder